New Findings on Polypharmacy in Depression New Findings on Polypharmacy in Depression
Dr Peter Yellowlees talks about mirtazapine added to SSRIs or SNRIs for treatment-resistant depression in primary care.Medscape Psychiatry (Source: Medscape Psychiatry Headlines)
Source: Medscape Psychiatry Headlines - March 11, 2019 Category: Psychiatry Tags: Psychiatry Commentary Source Type: news

Remeron SolTab (Mirtazapine) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - February 26, 2019 Category: Drugs & Pharmacology Source Type: news

mirtazapine (Remeron, Soltab)
Title: mirtazapine (Remeron, Soltab)Category: MedicationsCreated: 6/6/1999 12:00:00 AMLast Editorial Review: 12/3/2018 12:00:00 AM (Source: MedicineNet Depression General)
Source: MedicineNet Depression General - December 3, 2018 Category: Psychiatry Source Type: news

Popular drug combination for treatment resistant depression is not more effective than a single antidepressant in primary care
Psychiatrists and GPs increasingly combine mirtazapine with an SSRI (selective serotonin reuptake inhibitor) or SNRI (serotonin-noradenaline reuptake inhibitor) antidepressant for patients whose depression does not respond to a single antidepressant. A large clinical trial led by researchers at the Universities of Bristol, Exeter, Keele, Manchester and Hull York Medical School, and published in the British Medical Journal today, looked at the effectiveness of adding mirtazapine to an SSRI or SNRI in patients who remain depressed after at least six weeks of conventional (SSRI or SNRI) antidepressant treatment. They found th...
Source: University of Bristol news - November 1, 2018 Category: Universities & Medical Training Tags: Health; Faculty of Health Sciences, Faculty of Health Sciences, Bristol Medical School; Press Release Source Type: news

Drug combination for treatment resistant depression no more effective than single
(University of Bristol) A large clinical trial published in the British Medical Journal today, looked at the effectiveness of adding mirtazapine to an SSRI or SNRI in patients who remain depressed after at least six weeks of conventional (SSRI or SNRI) antidepressant treatment. They found that this combination was no more effective in improving depression than placebo and call on doctors to rethink its use. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 1, 2018 Category: International Medicine & Public Health Source Type: news

'Robbed of precious time': chemical restraints and aged care | Sarah Russell
Nearly two-thirds of aged care residents are prescribed psychotropic drugs regularly. Questions that must be urgently askedThis is part of a series about aged care in AustraliaMary ’s 85-year-old husband had been in an aged care home for just over a week. He had been getting frailer but was still sharp mentally. However, Mary* became extremely worried when her husband started sleeping all day.After much ado, Mary obtained access to the medication chart for her husband. The aged care home ’s GP had prescribed risperidone (an anti-psychotic medication), oxazepan (a benzodiazepine that is highly addictive and causes sedat...
Source: Guardian Unlimited Science - September 13, 2018 Category: Science Authors: Sarah Russell Tags: Ageing Science Society Source Type: news

A New Study Links Antidepressants to Weight Gain
A new study published in The BMJ has found that antidepressant use may be associated with weight gain over time. “Patients who were normal weight were more likely to transition to overweight, and overweight patients were more likely to transition to obesity if they were treated with antidepressants,” said study co-author Rafael Gafoor, a primary care and public health researcher at King’s College London, in an email to TIME. The researchers used data from the UK Clinical Practice Research Datalink, a large collection of electronic health records. Their analysis included almost 295,000 people of all differ...
Source: TIME: Health - May 23, 2018 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized healthytime Mental Health/Psychology onetime Source Type: news

Antidepressant May Help in PBC (CME/CE)
(MedPage Today) -- Mirtazapine use linked to reduced complications in primary biliary cholangitis (Source: MedPage Today Surgery)
Source: MedPage Today Surgery - April 12, 2018 Category: Surgery Source Type: news

These Antidepressants Are Most Effective, Study Says
Millions of people take antidepressants for depression. But there’s long been debate over just how effective the medications actually are. On Wednesday, a large new study provides evidence that antidepressants are more effective than placebo at treating acute depression in adults. The study, published in the journal The Lancet, looked at the published data from 522 randomized controlled trials testing 21 different types of antidepressants. The study authors also reached out to pharmaceutical companies and study authors for additional unpublished study data. All told, the data collection included 116,477 men and women...
Source: TIME: Health - February 21, 2018 Category: Consumer Health News Authors: Alexandra Sifferlin Tags: Uncategorized healthytime Mental Health/Psychology Source Type: news

Zydus Cadila gets USFDA nod for anti depressant
Zydus Cadila has received final approval from the US Food and Drug Administration (USFDA) to market the Mirtazapine orally disintegrating tablets USP in strengths 15mg, 30mg and 45mg, the company said in a BSE filing. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - June 5, 2017 Category: Pharmaceuticals Source Type: news

Mirtazapine fatal poisoning - Vignali C, Groppi A, Brandolini F, Avato FM, Talarico A, Gaudio RM, Morini L.
Mirtazapine is a noradrenergic and specific serotoninergic antidepressant agent that stimulates norepinephrine and serotonin release while also blocking serotonin receptors (5-HT2 and 5-HT3). Although the drug is used extensively, at present we do not know... (Source: SafetyLit)
Source: SafetyLit - May 29, 2017 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news

Non response at week 4 as clinically useful indicator for antidepressant combination in major depressive disorder. A sequential RCT - Kato M, Takekita Y, Koshikawa Y, Sakai S, Bandou H, Nishida K, Sunada N, Onohara A, Hatashita Y, Serretti A, Kinoshita T.
We aimed to compare the efficacy and tolerability of mirtazapine versus SSRIs and to assess whether "non-response at week 4" may be a clinical indicator for combining mirtazapine and SSRIs for subsequent treatment. One-hundred fifty-four outpatients with M... (Source: SafetyLit)
Source: SafetyLit - February 23, 2017 Category: Global & Universal Tags: Program and Other Evaluations, Effectiveness Studies Source Type: news

Poisoning suicide with ingestion of the pyrethroids alpha-cypermethrin and deltamethrin and the antidepressant mirtazapine: a case report - Boumba VA, Rallis GN, Vougiouklakis T.
This case report describes a death attributed to the intake of the pyrethroid insecticides, alpha-cypermethrin and deltamethrin, and the antidepressant mirtazapine. The autopsy findings showed absence of external traumatic injuries and internal generalized... (Source: SafetyLit)
Source: SafetyLit - December 10, 2016 Category: Global & Universal Tags: Poisoning Source Type: news

Remeron (Mirtazapine) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - September 1, 2016 Category: Drugs & Pharmacology Source Type: news

Considering Remeron for Depression? Here's What...
Remeron (mirtazapine) is an atypical antidepressant that operates by stimulating production of serotonin and norepinephrine. (Source: About.com Bipolar Disorder)
Source: About.com Bipolar Disorder - March 7, 2016 Category: Psychiatry Authors: bipolar.guide at about.com Tags: health Source Type: news